Managing and diagnosing fibromyalgia in psychiatry

Popy Arizona; Yunias  Setiawati

doi:10.15562/bmj.v12i2.4289

Managing and diagnosing fibromyalgia in psychiatry

Popy Arizona ,

Yunias Setiawati ,

pdf |
DOI: https://doi.org/10.15562/bmj.v12i2.4289 |
Published: 2023-04-08

Abstract

Fibromyalgia (FM) is a chronic pain syndrome that is quite common. This syndrome is often not diagnosed correctly because the symptoms are heterogeneous and often overlap with other diseases. In 2010, the American College of Rheumatology (ACR) established a feasible diagnostic criterion for FM then in 2016 ACR revised FM criteria. The clinical problems of FM vary widely and depend on the individual's management, depending on the severity and severity of the complexity, the degree of damage that occurs and the comorbidities in the psychiatric field that most commonly occur in anxiety disorders and depression.

References

Wolfe F, Walitt BT, Katz RS, Häuser W. Symptoms, the nature of fibromyalgia, and diagnostic and statistical manual 5 (DSM-5) defined mental illness in patients with rheumatoid arthritis and fibromyalgia. PLoS One. 2014;9(2):e88740. doi: 10.1371/journal.pone.0088740.
Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, Barton DL, St Sauver J. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken). 2013;65(5):786-92. doi: 10.1002/acr.21896.
Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: The Pathophysiology of Fibromyalgia. Ann Intern Med. 2007;146(10):726-34. doi: 10.7326/0003-4819-146-10-200705150-00006.
Staud R, Vierck CJ, Robinson ME, Price DD. Effects of the N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan on Temporal Summation of Pain are Similar in Fibromyalgia Patients and Normal Control Subjects. J Pain. 2005 May;6(5):323-32. doi: 10.1016/j.jpain.2005.01.357.
Arnold LM, Clauw DJ, McCarberg BH. Improving the Recognition and Diagnosis of Fibromyalgia. Mayo Clin Proc. 2011;86(5):457-64. doi: 10.4065/mcp.2010.0738.
Bennett RM. Clinical Manifestations and Diagnosis of Fibromyalgia. Rheum Dis Clin North Am. 2009;35(2):215-32. doi: 10.1016/j.rdc.2009.05.009.
McBeth J, Silman AJ. The Role of Psychiatric Disorders in Fibromyalgia. Curr Rheumatol Rep. 2001;3(2):157-64. doi: 10.1007/s11926-001-0011-8. PMID: 11286672.
Duque L, Fricchione G. Fibromyalgia and its New Lessons for Neuropsychiatry. Med Sci Monit Basic Res. 2019;25:169-178. doi: 10.12659/MSMBR.915962.
Higgs JB. Fibromyalgia in Primary Care. Prim Care. 2018;45(2):325-341. doi: 10.1016/j.pop.2018.02.008.
Ang DC, Chakr R, Mazzuca S, France CR, Steiner J, Stump T. Cognitive-behavioral therapy attenuates nociceptive responding in patients with fibromyalgia: a pilot study. Arthritis Care Res (Hoboken). 2010;62(5):618-23. doi: 10.1002/acr.20119.
Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318-328. doi: 10.1136/annrheumdis-2016-209724.
Lauche R, Cramer H, Dobos G, Langhorst J, Schmidt S. A systematic review and meta-analysis of mindfulness-based stress reduction for the fibromyalgia syndrome. J Psychosom Res. 2013;75(6):500-10. doi: 10.1016/j.jpsychores.2013.10.010.
Okifuji A, Hare BD. Management of Fibromyalgia Syndrome: Review of Evidence. Pain Ther. 2013;2(2):87-104. doi: 10.1007/s40122-013-0016-9.
Castillo-Saavedra L, Gebodh N, Bikson M, Diaz-Cruz C, Brandao R, Coutinho L, Truong D, Datta A, Shani-Hershkovich R, Weiss M, Laufer I, Reches A, Peremen Z, Geva A, Parra LC, Fregni F. Clinically Effective Treatment of Fibromyalgia Pain With High-Definition Transcranial Direct Current Stimulation: Phase II Open-Label Dose Optimization. J Pain. 2016;17(1):14-26. doi: 10.1016/j.jpain.2015.09.009.
Borchers AT, Gershwin ME. Fibromyalgia: A Critical and Comprehensive Review. Clin Rev Allergy Immunol. 2015;49(2):100-51. doi: 10.1007/s12016-015-8509-4.
Chinn S, Caldwell W, Gritsenko K. Fibromyalgia Pathogenesis and Treatment Options Update. Curr Pain Headache Rep. 2016;20(4):25. doi: 10.1007/s11916-016-0556-x.
Papadopoulou D, Fassoulaki A, Tsoulas C, Siafaka I, Vadalouca A. A meta-analysis to determine the effect of pharmacological and non-pharmacological treatments on fibromyalgia symptoms comprising OMERACT-10 response criteria. Clin Rheumatol. 2016;35(3):573-86. doi: 10.1007/s10067-015-3144-2.
Almassmoum, S. M., Balahmar, E. A., Almutairi, S. T., Albuainain, G., Ahmad, R., & Naqvi, A. A. (2018). Current clinical status of hydrotherapy; an evidence based retrospective six-years (2012-2017) systemic review. Bali Medical Journal, 7(3). https://doi.org/10.15562/bmj.v7i3.1159.
Ghazi-asgar, M., Peikari, H. R., & Ehteshami, A. (2018). Health Information Management: Psychological factors influencing information privacy concerns in psychiatric hospitals. Bali Medical Journal, 7(1), 120–126. https://doi.org/10.15562/bmj.v7i1.793.

[1] Wolfe F, Walitt BT, Katz RS, Häuser W. Symptoms, the nature of fibromyalgia, and diagnostic and statistical manual 5 (DSM-5) defined mental illness in patients with rheumatoid arthritis and fibromyalgia. PLoS One. 2014;9(2):e88740. doi: 10.1371/journal.pone.0088740.

[2] Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, Barton DL, St Sauver J. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken). 2013;65(5):786-92. doi: 10.1002/acr.21896.

[3] Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: The Pathophysiology of Fibromyalgia. Ann Intern Med. 2007;146(10):726-34. doi: 10.7326/0003-4819-146-10-200705150-00006.

[4] Staud R, Vierck CJ, Robinson ME, Price DD. Effects of the N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan on Temporal Summation of Pain are Similar in Fibromyalgia Patients and Normal Control Subjects. J Pain. 2005 May;6(5):323-32. doi: 10.1016/j.jpain.2005.01.357.

[5] Arnold LM, Clauw DJ, McCarberg BH. Improving the Recognition and Diagnosis of Fibromyalgia. Mayo Clin Proc. 2011;86(5):457-64. doi: 10.4065/mcp.2010.0738.

[6] Bennett RM. Clinical Manifestations and Diagnosis of Fibromyalgia. Rheum Dis Clin North Am. 2009;35(2):215-32. doi: 10.1016/j.rdc.2009.05.009.

[7] McBeth J, Silman AJ. The Role of Psychiatric Disorders in Fibromyalgia. Curr Rheumatol Rep. 2001;3(2):157-64. doi: 10.1007/s11926-001-0011-8. PMID: 11286672.

[8] Duque L, Fricchione G. Fibromyalgia and its New Lessons for Neuropsychiatry. Med Sci Monit Basic Res. 2019;25:169-178. doi: 10.12659/MSMBR.915962.

[9] Higgs JB. Fibromyalgia in Primary Care. Prim Care. 2018;45(2):325-341. doi: 10.1016/j.pop.2018.02.008.

[10] Ang DC, Chakr R, Mazzuca S, France CR, Steiner J, Stump T. Cognitive-behavioral therapy attenuates nociceptive responding in patients with fibromyalgia: a pilot study. Arthritis Care Res (Hoboken). 2010;62(5):618-23. doi: 10.1002/acr.20119.

[11] Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318-328. doi: 10.1136/annrheumdis-2016-209724.

[12] Lauche R, Cramer H, Dobos G, Langhorst J, Schmidt S. A systematic review and meta-analysis of mindfulness-based stress reduction for the fibromyalgia syndrome. J Psychosom Res. 2013;75(6):500-10. doi: 10.1016/j.jpsychores.2013.10.010.

[13] Okifuji A, Hare BD. Management of Fibromyalgia Syndrome: Review of Evidence. Pain Ther. 2013;2(2):87-104. doi: 10.1007/s40122-013-0016-9.

[14] Castillo-Saavedra L, Gebodh N, Bikson M, Diaz-Cruz C, Brandao R, Coutinho L, Truong D, Datta A, Shani-Hershkovich R, Weiss M, Laufer I, Reches A, Peremen Z, Geva A, Parra LC, Fregni F. Clinically Effective Treatment of Fibromyalgia Pain With High-Definition Transcranial Direct Current Stimulation: Phase II Open-Label Dose Optimization. J Pain. 2016;17(1):14-26. doi: 10.1016/j.jpain.2015.09.009.

[15] Borchers AT, Gershwin ME. Fibromyalgia: A Critical and Comprehensive Review. Clin Rev Allergy Immunol. 2015;49(2):100-51. doi: 10.1007/s12016-015-8509-4.

[16] Chinn S, Caldwell W, Gritsenko K. Fibromyalgia Pathogenesis and Treatment Options Update. Curr Pain Headache Rep. 2016;20(4):25. doi: 10.1007/s11916-016-0556-x.

[17] Papadopoulou D, Fassoulaki A, Tsoulas C, Siafaka I, Vadalouca A. A meta-analysis to determine the effect of pharmacological and non-pharmacological treatments on fibromyalgia symptoms comprising OMERACT-10 response criteria. Clin Rheumatol. 2016;35(3):573-86. doi: 10.1007/s10067-015-3144-2.

[18] Almassmoum, S. M., Balahmar, E. A., Almutairi, S. T., Albuainain, G., Ahmad, R., & Naqvi, A. A. (2018). Current clinical status of hydrotherapy; an evidence based retrospective six-years (2012-2017) systemic review. Bali Medical Journal, 7(3). https://doi.org/10.15562/bmj.v7i3.1159.

[19] Ghazi-asgar, M., Peikari, H. R., & Ehteshami, A. (2018). Health Information Management: Psychological factors influencing information privacy concerns in psychiatric hospitals. Bali Medical Journal, 7(1), 120–126. https://doi.org/10.15562/bmj.v7i1.793.

Managing and diagnosing fibromyalgia in psychiatry

Abstract

References

How to Cite

Search Panel